Elevated plasma endothelin-1 levels in diabetes mellitus

American Journal of Hypertension

Volumn 15, Issue 11, 2002, Pages 967-972

  Schneider, Jochen G ^a   Tilly, Nicole ^a   Hierl, Thomas ^a   Sommer, Ulrike ^a   Hamann, Andreas ^a   Dugi, Klaus ^a   Leidig Bruckner, Gudrun ^a   Kasperk, Christian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Diabetes mellitus; Endothelins; Metabolic control; Vascular complications

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; ENDOTHELIUM INJURY; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE; BLOOD; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; ENDOTHELIN-1; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 0036841258     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)03060-1     Document Type: Article

References (33)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
2. Rubanyi GM, Botelho LH: Endothelins. FASEB J 1991;5:2713-2720.
3. Schiffrin EL, Intengan HD, Thibault G, Touyz RM: Clinical significance of endothelin in cardiovascular disease. Curr Opin Cardiol 1997;12:354-367.
4. Lerman A, Hildebrand FL Jr, Aarhus LL, Burnett JC Jr: Endothelin has biological actions at pathophysiological concentrations. Circulation 1991;83:1808-1814.
5. Pacher R, Bergler-Klein J, Globits S, Teufelsbauer H, Schuller M, Krauter A, Ogris E, Rodler S, Wutte M, Hartter E: Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension. Am J Cardiol 1993;71:1293-1299.
6. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr: Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991;325:997-1001.
7. Vierhapper H, Wagner O, Nowotny P, Waldhausl W: Effect of endothelin-1 in man. Circulation 1990;81:1415-1418.
8. Saito Y, Nakao K, Mukoyama M, Imura H: Increased plasma endothelin level in patients with essential hypertension. N Engl J Med 1990;322:205.
9. Schiffrin EL, Thibault G: Plasma endothelin in human essential hypertension. Am J Hypertens 1991;4:303-308.
10. UK Prospective Diabetes Study: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-720.
11. Haak T, Jungmann E, Felber A, Hillmann U, Usadel KH: Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens 1992;5:161-166.
12. Perfetto F, Tarquini R, Tapparini L, Tarquini B: Influence of non-insulin-dependent diabetes mellitus on plasma endothelin-1 levels in patients with advanced atherosclerosis. J Diabetes Complications 1998;12:187-192.
13. Takahashi K, Ghatei MA, Lam HC, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia 1990;33:306-310.
14. Guvener N, Aytemir K, Aksoyek S, Gedik O: Plasma endothelin-1 levels in non-insulin dependent diabetes mellitus patients with macrovascular disease. Coron Artery Dis 1997;8:253-258.
15. Smulders RA, Stehouwer CD, Olthof CG, van Kamp GJ, Teerlink T, de Vries PM, Donker AJ: Plasma endothelin levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci (Colch) 1994;87:37-43.
16. Frelin C, Guedin D: Why are circulating concentrations of endothelin-1 so low? Cardiovasc Res 1994;28:1613-1622.
17. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhausl W, Binder BR: Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992;267:16066-16068.
18. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R: Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-509.
19. Miyauchi T, Yanagisawa M, Tomizawa T, Sugishita Y, Suzuki N, Fujino M, Ajisaka R, Goto K, Masaki T: Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet 1989;2:53-54.
20. Bertello P, Veglio F, Pinna G, Gurioli L, Molino P, Alban S, Chiandussi L: Plasma endothelin in NIDDM patients with and without complications. Diabetes Care 1994;17:574-577.
21. De Mattia G, Cassone-Faldetta M, Bellini C, Bravi MC, Laurenti O, Baldoncini R, Santucci A, Ferri C: Role of plasma and urinary endothelin-1 in early diabetic and hypertensive nephropathy. Am J Hypertens 1998;11:983-988.
22. Kawamura M, Ohgawara H, Naruse M, Suzuki N, Iwasaki N, Naruse K, Hori S, Demura H, Omori Y: Increased plasma endothelin in NIDDM patients with retinopathy. Diabetes Care 1992;15:1396-1397.
23. Collier A, Leach JP, McLellan A, Jardine A, Morton JJ, Small M: Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care 1992;15:1038-1040.
24. Hopfner RL, McNeill JR, Gopalakrishnan V: Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes. Eur J Pharmacol 1999;374:221-227.
25. McAllister AS, Atkinson AB, Johnston GD, McCance DR: Endothelial function in offspring of type I diabetic patients with and without diabetic nephropathy. Diabet Med 1999;16:298-303.
26. Zizek B, Poredos P, Videcnik V: Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension. Heart 2001;85:215-217.
27. Krum H, Viskoper RJ, Lacourciere Y, Budde M, Charlon V: The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med 1998;338:784-790.
28. Galatius-Jensen S, Wroblewski H, Emmeluth C, Bie P, Haunso S, Kastrup J: Plasma endothelin in congestive heart failure: Effect of the ACE inhibitor, fosinopril. Cardiovasc Res 1996;32:1148-1154.
29. Mullen MJ, Clarkson P, Donald AE, Thomson H, Thorne SA, Powe AJ, Furuno T, Bull T, Deanfield JE: Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: A randomized, double-blind study. J Am Coll Cardiol 1998;31:1330-1335.
30. Barton M, Shaw S, D'Uscio LV, Moreau P, Luscher TF: Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: Role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 1997;238:861-865.
31. D'Uscio LV, Shaw S, Barton M, Luscher TF: Losartan but not verapamil inhibits angiotensin II-induced tissue endothelin-1 increase: Role of blood pressure and endothelial function. Hypertension 1998;31:1305-1310.
32. Desideri G, Ferri C, Bellini C, De Mattia G, Santucci A: Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: In vitro and in vivo studies. Diabetes 1997;46:81-86.
33. Ferri C, Laurenti O, Bellini C, Faldetta MR, Properzi G, Santucci A, De Mattia G: Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition. Am J Hypertens 1995;8:40-47.